RENEFIL ULTRA PLUS

RENEFIL ULTRA PLUS Product Description

RENEFIL ULTRA PLUS is a premium hyaluronic acid-based dermal filler that uniquely combines cross-linked Hyaluronic Acid (HA), Polynucleotide (PN), and Lidocaine. Specifically designed for significant volume restoration and deep wrinkle correction, it provides superior elasticity, hydration, and long-lasting results, ensuring optimal patient comfort through the integrated lidocaine component.

RENEFIL ULTRA PLUS Key Features and Benefits

RENEFIL ULTRA PLUS is distinguished by its exceptional volume enhancement and sustained improvement in facial contours. It significantly enhances skin elasticity and hydration, promoting deep tissue regeneration through collagen stimulation. PN aids in longer-lasting results by improving skin structure and resilience.

• Significant volume enhancement
• Long-lasting results (up to 56 weeks)
• Enhanced skin elasticity and hydration
• Promotes deep collagen synthesis

RENEFIL ULTRA PLUS Composition

RENEFIL ULTRA PLUS contains highly effective active ingredients in precise concentrations:

• Cross-Linked Hyaluronic Acid: 20 mg/mL
• Polynucleotide (PN): 1.875 mg/mL
• Lidocaine HCl: 3.0 mg (0.3%) These ingredients offer robust volumizing, regenerative, and analgesic properties, ideal for deeper tissue injection.

RENEFIL ULTRA PLUS Intended Purpose / Indications

RENEFIL ULTRA PLUS is intended for the correction of deep wrinkles and significant volume loss. It is ideal for facial reshaping and volumizing in areas such as cheeks, nasolabial folds, chin augmentation, and nasal reshaping, providing structural support and substantial rejuvenation.

• Deep wrinkle correction
• Volume restoration in cheeks and chin
• Nasolabial folds treatment

RENEFIL ULTRA PLUS Injection and Treatment Areas

RENEFIL ULTRA PLUS should be injected into the deep dermal or subcutaneous layers, suitable for enhancing facial structures and correcting pronounced facial folds. Key treatment areas include deep nasolabial folds, cheeks, chin, nose augmentation, and zygomatic contouring.

• Deep dermal/subcutaneous injection
• Cheeks, chin, deep nasolabial folds, nose, zygomatic area

RENEFIL ULTRA PLUS Reconstitution and Preparation Guidelines

RENEFIL ULTRA PLUS is provided ready-to-use in a sterile pre-filled syringe. No additional dilution is necessary. Employ strict aseptic procedures during preparation and injection, ensuring the syringe is free from air bubbles to prevent complications.

• No dilution necessary
• Ready-to-use pre-filled syringe
• Aseptic handling mandatory

RENEFIL ULTRA PLUS Administration and Dosage

Administration of RENEFIL ULTRA PLUS must be conducted by trained healthcare professionals. Dosages typically range from 1.0 to 3.0 mL per site, depending on the area treated and desired outcomes. The injection must be administered slowly and carefully, maintaining patient comfort throughout.

• Dosage: 1.0-3.0 mL per area
• Slow, careful injection technique

RENEFIL ULTRA PLUS Storage Instructions

Optimal storage of RENEFIL ULTRA PLUS is critical for efficacy and safety. Store at temperatures between 2–25°C, away from direct sunlight, avoiding extreme temperatures and freezing. Use immediately upon opening to maintain sterility.

• Storage: 2–25°C
• Protect from sunlight
• Avoid freezing

RENEFIL ULTRA PLUS Contraindications

Do not use RENEFIL ULTRA PLUS in patients with known hypersensitivity to hyaluronic acid, lidocaine, or other filler components. Contraindications include active infections, inflammatory skin conditions, autoimmune disorders, and during pregnancy or breastfeeding.

• Allergies to components
• Active skin conditions
• Pregnancy and lactation

RENEFIL ULTRA PLUS Precautions and Warnings

To prevent complications, caution should be taken to avoid intravascular injections that could cause vascular complications. RENEFIL ULTRA PLUS should not be used simultaneously with other fillers at identical injection points. Comprehensive patient evaluation and medical history assessment are critical for safety.

• Avoid intravascular injections
• Do not mix with other fillers

RENEFIL ULTRA PLUS Post-Treatment Care

Post-treatment care involves avoiding makeup for at least 24 hours, limiting UV exposure, and refraining from extreme temperature exposure (saunas, steam rooms) for one week to optimize healing and reduce the risk of side effects.

• Avoid makeup for 24 hours
• Limit UV and temperature exposure

RENEFIL ULTRA PLUS Side Effects and Adverse Reactions

Typical side effects include temporary redness, swelling, tenderness, bruising, or lumps at the injection site. Severe reactions, though rare, require immediate medical attention and include prolonged swelling, intense pain, or symptoms of infection.

• Common: Swelling, bruising, redness
• Severe reactions require urgent care

RENEFIL ULTRA PLUS Patient Eligibility

Ideal patients for RENEFIL ULTRA PLUS are aged 18-65, seeking deep wrinkle correction or significant facial volume enhancement. Candidates must have good general health and no contraindicated medical conditions.

• Adults 18-65 years old
• Good general health required

RENEFIL ULTRA PLUS Follow-Up and Maintenance

Initial follow-up is recommended after 4 weeks to evaluate results. Maintenance sessions should be scheduled every 9-12 months to sustain long-term aesthetic results.

• Initial follow-up after 4 weeks
• Maintenance every 9-12 months

RENEFIL ULTRA PLUS Manufacturer and Regulatory Information

Manufactured by BMI Korea Co., Ltd., RENEFIL ULTRA PLUS meets stringent international quality standards including ISO 13485:2016 and holds CE certification, ensuring the highest product quality and safety.

• Manufacturer: BMI Korea Co., Ltd.
• Compliance: ISO 13485, CE certification

RENEFIL ULTRA PLUS FAQ

When will I notice RENEFIL ULTRA PLUS results? Results are visible immediately, with continuing improvement over subsequent weeks.

Is treatment with RENEFIL ULTRA PLUS painful? Lidocaine inclusion significantly reduces discomfort, making the treatment relatively painless.

How durable is RENEFIL ULTRA PLUS? Effects typically last up to 56 weeks, varying individually.

Can normal activities resume immediately? Most normal activities can resume immediately; intense physical activities should be postponed for 24-48 hours post-treatment.